Wednesday, February 27, 2019

Uterine Fibroid Market Key Developments Trends, Analysis and Forecasts to 2022

Uterine Fibroids are the abnormal growth that gets developed inside or on the wall of a woman’s uterus. These are also known as leiomyoma or myomas. These are noncancerous growths that cause symptoms such as heavy bleeding between or during the menstrual cycle, pain in pelvis or lower back, increased menstrual cramping, swelling enlargement of the abdomen. Increasing prevalence due to heredity and rising number of treatments to cure this disease has fuelled the growth of this market. 
The U.S. Market for Uterine Fibroids is expected to reach USD 39,993.2 million by the end of the forecasted period and is expected to grow at a CAGR of 3.24%.

Uterine Fibroid Market Segmentation:

U.S. Uterine Fibroid Market has been segmented on the basis of type which comprises of Subserosal Fibroids, Intramural Fibroids, Submucosal Fibroids and others. On the basis of diagnosis the market is segmented into Medical Resonance Imaging (MRI) scanners, Computed tomography (CT), Ultrasounds and others. On the basis of treatment the market is segmented into Uterine Fibroid Embolization, Magnetic Resonance Guided Focused Ultrasound, Myolysis, Endometrial Ablation, Hysterectomy and Myomectomy.


Intended Audience
  • Uterine Fibroid Devices and Drug Manufacturers
  • Uterine Fibroid Devices and Drug Suppliers
  • Private Research Laboratories
  • Research and Development (R&D) Companies
  • Market Research and Consulting Service Providers
  • Medical Research Laboratories
Key Players

Some of the key players in the global Uterine Fibroid market are STERIS Corporation (U.K.), Getinge Group (Sweden), Cantel Medical Corporation (U.S.), Ecolab (U.S.), 3M Healthcare Company (U.S.), Sotera Health (U.S.), Advanced Sterilization Products (U.S.), MMM Group (Germany), Matachana (Spain), Belimed AG (Switzerland), Halyard Health (U.S.), Metrex Research (U.S.), Reckitt Benckiser (U.K.), Pal Internation (U.K.), Nordion, Inc. (U.S.), Ahlstrom Corporation (Finland), Honeywell International, Inc. (U.S.), and others.

Regional Analysis

The U.S. market for uterine fibroids is growing steadily. The market for uterine fibroids is growing with the CAGR of 3.24% during the forecast period from 2016-2022. California, Texas, Florida, New York are some of the states which are estimated to have highest prevalence of uterine fibroids.                         

The report for U.S. Uterine Fibroid Market of Market Research Future comprises extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.
Table Of Content

1. Introduction
1.1.1 Prevalence Of The Uterine Fibroids In U.S. 8 
2. Scope of Study
3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
4. US Uterine Fibroid Market
4.1 Introduction 15 
4.2 U.S. Uterine Fibroid Market, By Type 17 
4.3 U.S. Uterine Fibroid Market, By Diagnosis 19 
4.4 U.S. Uterine Fibroid Market, By Treatment 21 
TOC Continued….!

Browse Complete Report Details @

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Posted by at No comments:

The Hernia Repair Market Segments, Key Players Strategies, Analysis and Forecasts to 2022

The market for hernia repair is growing steadily and expected to continue its growth similarly in near future.  Hernia can be caused due to anything that causes an increase in pressure in the abdomen. Hernia is a protrusion of an organ through a weak spot in the surrounding connective tissue called as a fascia.

Some of the major factors in the advancements in the hernia repair such as transition into tension-free technique that incorporates the use of flat sheets of mesh instead of sutures, adoption of large pore meshes, and the adoption of laparoscopic surgeries instead of conventional open technique. Laparoscopic surgery being the minimally invasive surgery has several advantages over conventional open tension-free surgery.

There are various hernia devices and consumables used worldwide. Companies like Medtronic has hernia repair products range which includes Spacemaker Pro Access & Dissector System, Versatex Monofilament Mesh, ReliaTack Articulating Reloadable Fixation Device, Symbotex Composite Mesh, ProGrip Laparoscopic Self-Fixating Mesh, AccuMesh Positioning System, Parietex Composite Ventral Patch, AbsorbaTack (ABSTACK30X) Fixation Device, and others.


Key Players

Some of the key players in this market are: ABISS, A.M.I. GmbH, Angiologica B.M., Aspide Medical, Atrium Medical Corporation, B. Braun Melsungen AG, Baxter Internationals, C. R. Bard, Inc. (Davol Inc), COOK MEDICAL INC., Cousin Biotech, Covidien (Medtronic), Ethicon, Integra LifeSciences Corporation, and others.

Competitive Analysis

A.M.I. GmbH (Austria), Angiologica B.M. (Italy), Aspide Medical (France), Atrium Medical Corporation (Germnay), B. Braun Melsungen AG (Germany), Baxter Internationals (U.S.), C. R. Bard, Inc. (Davol Inc) (U.S.), COOK MEDICAL INC. (U.S.), Cousin Biotech (France), Covidien (Medtronic) (Republic of Ireland), Ethicon (U.S.), Integra Life Sciences Corporation (U.S), and ABISS (France) are some of the prominent players at the forefront of competition in the Global Hernia Repair Market and are profiled in MRFR Analysis. 

October, 2015 - Cook Medical demonstrated Zenapro, hernia repair technology which is a next-generation hybrid that combines outer layers of extracellular matrix with a polypropylene mesh. This technology is already cleared by regulatory agencies (FDA) and available in the U.S. and Europe market, the Zenapro Hybrid Hernia Repair Device integrates a layer of strong, open-weave polypropylene mesh within several layers of small intestinal sub- mucosa extracellular matrix (ECM) biomaterial.

March, 2014 - Covidien had launched its Symbotex composite mesh in the U.S. market for surgical laparoscopic and open ventral hernia repair. This hernia repair product featured a macro porous monofilament, hydrophilic textile in a three-dimensional construction that allowed reinforced strength, memory shape and significant tissue ingrowth and this product includes a bio absorbable collagen film on the visceral side which minimises tissue attachments.

Regional Analysis

Depending on geographic region, hernia repair market is segmented into four key regions: Americas, Europe, Asia-Pacific, and Middle East & Africa. Considering the global scenario of the market, Americas region is believed to be the largest market for hernia repair. North America is the leading market in the America region due to increasing hernia patient population, increasing adoption of minimal invasive surgeries. Moreover, minimally invasive means the degree of invasiveness of the procedure is minimum, thus, is also referred as key whole surgery. At the University of Chicago Medicine, over 70% of major lung resection surgeries are performed using minimally invasive techniques. Furthermore, the European market is also growing continuously and slowly catching up with the American market in the near future. On the other hand, Asia-Pacific market is expected to grow at the fastest pace in the hernia repair segment during the forecasted period. Middle East & Africa region are likely to have a limited but steady growth in the market.  

Table Of Content

Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porters Five Forces Analysis
5.1.1 Bargaining Power Of Suppliers
        TOC Continued….!

Browse Complete Report Details @

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Posted by at No comments:

Thursday, February 21, 2019

The Biopreservation Market Segments, Key Players Strategies, Analysis and Forecasts to 2023

Biopreservation plays an important role in healthcare and food industry. It helps to preserve the biological product or material. It uses natural flora of biological material or the products of natural flora to preserve the product. The increasing expenditure on healthcare, a growing number of in vitro fertilization (IVF) centers, increasing awareness about stem cell and its applications are the major factors driving the growth of the global biopreservation market. 
The global biopreservation market is expected to grow during the forecast period (2018–2023) at a CAGR ~11.2%.
The high cost associated with biopreservation instruments and its maintenance, stability issues related to the specimen and lack of skilled personnel for handling the biopreservation process may hamper the growth of the market during the assessment period.

Biopreservation Market Segmentation:

The global biopreservation market has been segmented on the basis of product, biospecimen, and application.
The market, by source, has been segmented into regenerative medicine, biobanking, and drug discovery. On basis of regenerative medicine, the market has been divided into cell therapy, gene therapy, and others. Biobanking segment includes human egg, human sperm, and veterinary IVF.

The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The biopreservation market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.

The European biopreservation market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. 
The biopreservation market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The biopreservation market in the Middle East & Africa has been segmented into the Middle East and Africa.


Key Players

Some of the key players in the global biopreservation market are Thermo Fisher Scientific, Inc, VWR International, LLC., CUSTOM BIOGENIC SYSTEMS., BioLifeSolutions Inc., BioCision, Sigma-Aldrich Co., QIAGEN, Lifeline Scientific, Cesca Therapeutics Inc., Core Dynamics, Ltd., Princeton CryoTech, Biomatrica, Inc., Panasonic Biomedical, Inc., Chart Industries, and ATLANTA BIOLOGICALS

Regional Analysis

The market in the Americas is expected to dominate the global biopreservation market during the forecast period owing to the increasing organ transplantation, increasing healthcare expenditure, and well-established healthcare sector in the region. The European market is expected to be the second-largest due to government funding and support of the healthcare sector and an increasing number of births and with-it continuous increase in demand for umbilical cord preservation. Moreover, the market in Asia-Pacific is anticipated to be the fastest-growing during the forecast period owing to technological development, increasing awareness about stem cell and its applications, and favorable government initiatives for healthcare facilities. The market in the Middle East & Africa is likely to account for the smallest share of the global biopreservation market. The market growth in this region can be attributed to increasing healthcare expenditure and technological advancement in the region.

Table Of Content

Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
TOC Continued….!

Browse Complete Report Details @

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Posted by at No comments:

Thursday, February 14, 2019

Global Digital Therapeutics Market by Type and Size | Industry Report 2018-2023

Digital therapeutics is an emerging healthcare discipline that through the use of digital and internet-based solutions treat a medical condition. These therapeutics present the opportunity to increase or replace prescription drug as a sole therapy, using tech-based solutions. Digital therapeutics are either in a standalone fashion or in combination with more conventional medical therapy built on the concept of using software to improve a patient’s health conditions simultaneously using a drug therapy, at a much-reduced cost and no physical side effects. 

Effective functionality of digital therapeutics has been linked to medical conditions such as diabetes, obesity, and hypertension among others. With the several options available for treatment, ranging from behavioral intervention to prescription medication the digital therapeutics market appears to be a well-established space.  Additionally, digital therapeutics provide good outcomes, easing the conditions to an extent. Resultantly, the global digital therapeutics market is growing pervasively.

Considering the traction, the market is vibrating with; Market Research Future (MRFR) in its recently published study report asserts that the global digital therapeutics market gaining further prominence will register a spectacular growth by 2023, with a striking CAGR throughout the forecast period (2018 – 2023). The burgeoning healthcare sector along with the proliferation of advanced HC facilities substantiates the market growth.

Digital Therapeutics Market Segmentation:

The segmental analysis of the digital therapeutics market is done on the basis of product type, application, and sales channel.

By mode of product, the segmentation has divided into software and devices.

By mode of application, the market segmentation has been done into cardiovascular diseases, obesity, diabetes, respiratory diseases, smoking cessation, and others.

By sales channel mode, the segmentation of the market has been divided into B2B and B2C..


Key Players

Some of the leaders of the market include Proteus Digital Health, Inc., Twine Health Inc., Mango Health, Inc., Canary Health Inc., Propeller Health, Medtronic Plc., WellDoc Inc., Noom Inc, Inc., Livongo Health, and Omada Health.

Regional Analysis

The North America market dominates the global digital therapeutics market holding the largest share, followed by the markets in the European and Asia Pacific region, respectively. The US backed by the high healthcare expenditures accounts for the largest contributor to the regional market.  The North American region is projected to retain its dominance over the global digital therapeutics market throughout the forecast period, following the same growth trends.

The Asia Pacific market is emerging as a lucrative market for digital therapeutics owing to the ever-increasing population, large unmet needs, and the availability of the treatment. The improving economy accounts for one of the key driving forces behind the market growth. The growing markets in India and China provide colossal impetus to the market growth.

Simultaneously, market penetration of healthcare insurance mainly in the countries such as Thailand, Malaysia, and Vietnam among the other South East Asian countries are expected to drive the digital therapeutics market in the in the APAC region.

Increasing funding support from the public and private bodies are supporting the market growth in the region, increasing R&D activities. Furthermore, heading with the availability of new treatment methods that are increasingly meeting the growing demand for the treatments, the APAC region is expected to register a substantial CAGR over the assessment period.

Table Of Content

Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
        TOC Continued….!

Browse Complete Report Details @

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Posted by at No comments:

Wednesday, February 13, 2019

Inguinal Hernia Market Worldwide Key Players Revenue, Share and Forecasts to 2023

Inguinal hernia is a condition in which a part of small intestine bulges through its walls. It is one of the types of hernia, which is the most common in both the developing and developed countries across the globe.

The global inguinal hernia market is expected to show a high growth over the forecast period owing to rising number of patients with inguinal hernia and increasing number of surgical procedures performed for hernia repair.  

Furthermore, growing demand for hernia repair devices boost the market growth. However, high cost hernia repair devices restrains the growth of the market in nations in Africans region and other developing countries.

The global inguinal hernia market is expected to grow at a CAGR of 10.7% during the forecast period.

Inguinal Hernia Market Segmentation:

The global inguinal hernia market is segmented on the basis of type, diagnosis, treatment and hernia mesh devices.
On the basis of types, market is segmented into direct and indirect hernia. 

On the basis of diagnosis, the market is segmented into physical examination and imaging test. Imaging tests is further segmented into abdominal ultrasound, CT scan and Magnetic Resonance Imaging (MRI).

On the basis of treatment, the market is segmented into open hernia repair, laparoscopy, and others.

On the basis of hernia mesh devices, the market is segmented into synthetic mesh, and biologic mesh.


Key Players

Some of the key players in the global market are Ethicon, Inc. (U.S.), Medtronic (U.S.), C.R. Bard, Inc. (U.S.), Atrium (U.S.), W.L. Gore & Associates Inc. (U.S.), Acelity (U.S.), and B Braun Melsungen AG (Germany).

Regional Analysis

America is the largest market for inguinal hernia owing to rising prevalence in the U.S. and increasing surgical procedures cases such as groin hernia repair.

Europe is the second largest market owing to increasing prevalence of inguinal hernia and extensive demand for hernia repair devices. The U.K is expected to be the largest market in Europe over the review period.  According to the New England Journal of Medicine, in 2014 more than 90,000 surgical intervention for inguinal hernia were performed in Europe.

In Asia Pacific, rising demand for laparoscopic procedures for inguinal hernia. India is expected to be the largest market in Asia Pacific followed by China and Japan.

The Middle East & Africa also shows a steady rise in the market owing to extensive use of hernia mesh devices for surgeries in the Middle East. In the Middle East, Iran is expected to be the largest market followed by Saudi Arabia. In Africa, high cost of hernia repair restrained the market growth.

Table Of Content

1 Report Prologue
2 Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
2.3 Market Structure
3 Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
3.5 Forecast Model
       TOC Continued….!


About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Posted by at No comments:

Infection Control Market Industry Booming Demand by Top Regions and Major Segments Till 2023

Many microorganisms such as virus, fungi, and bacteria are the causative agents for infections. These infections can be categorized into several types including stomach and intestinal infections, Hospital Acquired Infections (HAIs), eye infections, common childhood infections, ear infections, skin infections, lung and respiratory infections, and Sexually Transmitted Infections (STDs). 

There are numerous steps for the controlling and prevention of such infections. For example, the most effective way to prevent the spread of HAIs in hospitals is a proper hand wash. Few other steps include immunizations, using protective clothing such as masks and gloves, covering while coughing and sneezing, and others.

Many companies are undergoing collaborations for developing and novel product launches. For instance, in March 2017, Kimberly-Clark Health Care and 3M Healthcare Company signed an alliance for co-developing and delivering surgical and infection prevention solutions utilizing their respective expertise. This deal was expected to be implemented by the end of 2017.

The global market for infection control is expected to have a CAGR of approximately 7.5% during 2017 to 2023.

Infection Control Market Segmentation:

The global infection control market has been segmented on the basis of type and end-user.

On the basis of type, the global infection control market can be segmented into disinfection products, sterilization products and services, and others.

Disinfection products are categorized into disinfectants, medical nonwovens, disinfectors, and endoscope reprocessors.

Disinfectants are categorized into type, formulation, and EPA classification.

Disinfectants by type are classified into hand disinfectants, skin disinfectants, instrument disinfectants, and surface disinfectants. The disinfectant by formulation is categorized into disinfectant wipes, disinfectant liquids, and disinfectant sprays. The EPA classification is categorized into low-level disinfectants, intermediate-level disinfectants, and high-level disinfectants.

Medical nonwovens are classified into surgical drapes, surgical gowns, sterilization wraps, and face masks. 

Disinfectors are classified into washer disinfectors, flusher disinfectors, and UV ray disinfectors. The endoscope reprocessors are classified into automated endoscope reprocessors, endoscope tracking systems, and other endoscopic reprocessing products.


Key Players

Some of the key players in the global infection control market are STERIS Corporation (U.K.), Getinge Group (Sweden), Cantel Medical Corporation (U.S.), Ecolab (U.S.), 3M Healthcare Company (U.S.), Sotera Health (U.S.), Advanced Sterilization Products (U.S.), MMM Group (Germany), Matachana (Spain), Belimed AG (Switzerland), Halyard Health (U.S.), Metrex Research (U.S.), Reckitt Benckiser (U.K.), Pal Internation (U.K.), Nordion, Inc. (U.S.), Ahlstrom Corporation (Finland), Honeywell International, Inc. (U.S.), and others.

Regional Analysis

The global infection control market consists of regions, namely, the Americas, Europe, Asia Pacific, and the Middle East and Africa.

The Americas dominated the global infection control market owing to the constant technological innovations due to the increasing competitiveness among the key players to ensure proper sterilization and disinfection, growing demand for infection control products and services for minimizing the prevalence of Hospital Acquired Infections (HAIs), and increasing number of surgical procedures in the region.

The European region is the second largest market for global infection control due to the adoption of new therapies, skilled medical professionals, and availability of advanced treatment facilities.

The increase in awareness of infections and other diseases coupled with the aging population and the penetration of key players in the region are factors that drive the market growth of infection control in emerging countries of Asia Pacific. Besides, the growing initiatives of World Health Organization (WHO) in countries such as India, China, and Japan are likely to foster the strengthening of major Asian countries in the future.

The Middle East and Africa is projected to show steady growth in this market due to the increasing prevalence of infectious diseases along with the demand for diagnosis of infections in remote areas.

Table Of Content

Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
        TOC Continued….!

Browse Complete Report Details @

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Posted by at No comments:

Hemifacial Spasm Market Concerns over the Rising Healthcare Costs Propel the Market to a High CAGR ~7.5% Forecasts Till 2023

Hemifacial spasm is a condition that causes frequent muscle spasms, on one side of the face. The condition can affect both men and women, but it is most prevalent in middle-aged or older women. Its incidence rate is also found to be higher among the Asian population.

A number of factors such as increasing technological advancements, rising public awareness, increased incidence of craniofacial tremor, and facial chorea, unmet medical needs, increasing government assistance, improving regulatory framework, increasing adoption rate, and improvement in funding and reimbursement policies are propelling the growth of the global hemifacial spasm market.

However, difficult diagnosis, cost of treatment, side-effects of botulinum toxin, the presence of misbranded and spurious drugs, and poor healthcare system in low and middle-income countries may hamper the growth of the market over the review period.

It is estimated that the hemifacial spasm market is expected to grow at a CAGR 7.5% during the forecast period of 2017-2023.

Hemifacial Spasm Market Segmentation:

The global hemifacial spasm market is segmented on the basis of diagnosis, treatment, and end user.
On the basis of the diagnosis, the market is classified as a magnetic resonance imaging (MRI), computed tomography (CT or CAT scan), angiography (Arteriography), and others.

On the basis of the treatment, the market is classified as medical treatment, surgical treatment, combinational therapy, transcutaneous electric nerve stimulation (TENS) therapy, physical therapy, and others. The medical treatment is further classified into Botulinum Neurotoxin (BoNT) Injections and Pharmaceuticals. The sub-segment of Botulinum Neurotoxin (BoNT) Injections includes BoNT-A, BoNT-B, onabotulinumtoxinA, incobotulinumtoxinA, and rimabotulinumtoxinB. The sub-segment of pharmaceuticals include anticonvulsants, and GABAergic drugs. The surgical treatment is further classified into microvascular decompression (MVD), and others.
On the basis of the end user, the market is segmented into hospitals, clinics, diagnostic centers, drug stores, pharmacies, and others.


Key Players

Some of key the players in the global hemifacial spasm market are Abbott, Allergan, Inc., Cephalon Inc., GlaxoSmithKline plc, Ipsen Group, Johnson & Johnson Services, Inc., Medytox,Inc., Merz Pharma GmbH and Co. KGaA, Novartis AG, Pfizer, Revance Therapeutics, Inc., ROCHE, Sanofi S.A, Shire plc, Stryker, Sunovion Pharmaceuticals, Inc., UCB S.A., US WorldMeds, LLC., and Valeant Pharmaceuticals International, Inc.

Regional Analysis

The Americas dominate the hemifacial spasm market owing to the rising technological advancements and high healthcare expenditure. According to the Centers for Disease Control and Prevention in 2015, the total health expenditure in the United States was reported to be USD 3.2 trillion, and hospital care accounted for a share of 32.3%.

Europe holds the second position in the hemifacial spasm market. It is expected that the support provided by the government bodies for research & development and improvement in reimbursement policies in the healthcare is likely to drive the European market.

The Asia Pacific is the fastest growing hemifacial spasm market owing to a huge patient pool and developing healthcare technology. Healthcare expenditure is also improving in various Asia Pacific countries. According to the Australian Institute of Health and Welfare in the years 2015-2016, the total health expenditure was USD 170.4 billion, which is 3.6% higher than the expenditure of 2014-2015. An increasing prevalence rate among Asian population is also propelling the growth of the market.

The Middle East & Africa holds the lowest share of the global market due to lack of technical knowledge and poor medical facilities.

Table Of Content

Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
       TOC Continued….!

Browse Complete Report Details @

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Posted by at No comments:

The Appendicitis Market Segments, Key Players Strategies, Analysis and Forecasts to 2023

Market Highlights:

Appendicitis is a medical condition involving the inflammation of appendix, a small tube at the end for the intestine. It is can be diagnosed by physical examination, and imaging tests such as CT scan, ultrasound, X-ray, and others. Antibiotics and surgery are commonly used for the treatment of appendicitis.

The global appendicitis market is expected to exhibit moderate growth during the forecast period. Technological advancement governs the global appendicitis market. Additionally, increasing prevalence of acute and chronic appendicitis, and increasing emphasis on early diagnosis of the disease also support the progress of the market.
The market for appendicitis is expected to grow at a CAGR of 4.2%.

Appendicitis Market Segmentation:

The global appendicitis market is segmented on the basis of type, diagnosis, treatment, and end user.
On the basis of type, the market is segmented into acute, and chronic appendicitis.

On the basis of diagnosis, the market is segmented into physical examination, White Blood Cell count, urinalysis, and imaging test.  Imaging Test is further segmented into abdominal X-ray, ultrasonography, CT scan, laparoscopy, and others

On the basis of treatment, the market is segmented antibiotics, appendectomy, and others.

On the basis of end user, the market is segmented into hospitals & clinics, diagnostic centers, and others.


Key Players

There are plenty of large and small market players which operate in this market: Siemens (U.S.), General Electric Company (U.S.), Toshiba Medical Systems Corporation (Japan), Koninklijke Philips N.V. (Japan), Johnson & Johnson Services Inc. (U.S.), Pfizer (U.S.), Shionogi & Co., Ltd. (Japan), and others.

Regional Analysis

In America, the market is expected to grow at an exponential rate owing to various factors such as such extensive used of technologically advanced diagnostics devices such as CT scan, and availability of advanced surgical devices in tertiary care centers. North America is the largest market driven by rising prevalence of chronic diseases, and increasing awareness about available treatment options for appendicitis among the population. Healthcare expenditure in the U.S. has increased from last few years, which will lead to extensive growth of medical device industry, thus accelerating the market growth.

In Europe, Germany, France, and U.K are the largest contributors to the growth of the market.  The market is mainly governed by the increasing number of medical device companies in the European region. Additionally, pharmaceutical companies have also shown a significant growth from last few years, which will further contribute to the market growth.

Asia Pacific is expected to be the fastest growing market due to splendid growth of healthcare sector, and rise in healthcare expenditure in developing countries such as India, and increasing awareness about imaging technologies, and treatment options for chronic diseases.

The Middle East & Africa exhibit positive growth in the market.

Table Of Content

1. Report Prologue
2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
TOC Continued….!

Browse Complete Report Details @

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Posted by at No comments:

Acute Myeloid Leukemia Treatment Market Industry Booming Demand by Top Regions and Major Segments Till 2023

Acute myeloid leukemia (AML) is a cancer of the myeloid blood cells, causing extreme and rapid growth of abnormal white blood cells of the bone marrow. The rapid buildup of abnormal white blood cells causes interference in the production of normal blood cells. AML has a propensity to increase towards age. Replacement of normal bone marrow with cancer cells causes a drop in blood constituents such as red blood cells, platelets, white blood cells etc.

Considering all these factors the market for acute myeloid leukemia treatment is expected to reach $ 1.2 billion by the end of 2023, this market is projected to growing at a CAGR of Approx 5.3 % during 2017-2023.

Increasing diagnoses of AML are due to exposure to carcinogenics which are present everywhere. Changing lifestyles have given rise to unhealthy habits which lead to cancer. AML can also be passed genetically, and increased prevalences of cancer combined with the growing population drive the market. Other key factors of note which are affecting the market include improving reimbursement policies, and increasing number of cancer hospitals staffed with specialists to specifically treat cancers like AML. Supportive funding for research and development of treatment for this swiftly progressing diseases is expected to offer various opportunities for growth. Awareness regarding actual myeloid leukemia has been observed to be increasing and is likely to increase diagnoses and lead to growth over the forecast period. However, the side effects associated with drugs used for treatment currently and the availability of effective medication are challenging the growth of the market.


Market Segmentation

The global acute myeloid leukemia treatment market is segmented on the basis of disease type, treatment, and region. By disease type, the market is segmented into promyelocytic, myeloblastic, myelomonocytic, monocytic, megakaryocytic and erythroleukemia.

By treatment, the market is segmented into chemotherapy and hematopoietic stem cell transplantation. The chemotherapy segment is further segmented into post remission and induction.

The regional segmentation of the AML treatment market divides the globe into North America, Europe, Asia Pacific and the Middle East and Africa.

Regional Analysis

Led by the US, North America accounts for the largest share of the global market. The presence of various market-leading players and increasing investments in R&D for drug development drives the market. The region has favorable reimbursement policies and high healthcare expenditure which bring it to the forefront of the global acute myeloid leukemia treatment market. Europe follows the North American market due to a large number of hospitals present in the region combined with high disposable incomes. North America and Europe follow similar growth patterns.

The Asia Pacific is expected to grow at the highest CAGR during the review period due to large unmet potential present in the region. Countries such as India and China are anticipated to drive demand for AML treatment. The rapid growth in the region's economy combined with a growing demand for advanced healthcare is expected to encourage considerable growth for the APAC.

Key Players

The competitive analysis of the global AML market reveals key strategies used by various leading market players. Prominent players included in the report are Ambit Biosciences Corporation, Novartis AG, Sanofi, Cyclacel Pharmaceuticals Inc., Bristol Myers Squibb, Celgene Corporation, Johnson & Johnson, and Pfizer Inc.

Table Of Content

1 INTRODUCTION
1.1 DEFINITION
1.2 SCOPE OF STUDY
1.2.1 RESEARCH OBJECTIVE
1.2.2 ASSUMPTIONS & LIMITATIONS
1.2.2.1 ASSUMPTIONS
1.2.2.2 LIMITATIONS
1.3 MARKET STRUCTURE:
2 RESEARCH METHODOLOGY
2.1 RESEARCH PROCESS:
2.2 PRIMARY RESEARCH
2.3 SECONDARY RESEARCH:
3 MARKET DYNAMICS
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 MACROECONOMIC INDICATORS
      TOC Continued….!

Browse Complete Report Details @

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Posted by at No comments:
Subscribe to: Posts (Atom)